investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

FOXD3 Up-Regulation and ERBB3 Signaling as an Adaptive Response to RAF Inhibitors

Andrew E Aplin

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Andrew E Aplin

Thomas Jefferson University

Philadelphia, United States

Thore Kettmann

U3 Pharma Gmbh

Martinsried, Germany

Related projects

John A Tainer

Structural Biology of XPB and XPD Helicases

Melanoma of skin

Pathology

Isaac Brownell

Clinical Treatment of Advanced Merkel Cell Carcinoma

Melanoma of skin

Pathology

Hans Schreiber

Manipulation of Tumor Specific Immunity

Melanoma of skin

Pathology

Douglas R Green

RIPK-dependent necrosis in development and cancer

Melanoma of skin

Pathology

Arthur Hurwitz

The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity

Melanoma of skin

Pathology

Shengyu Yang

Store-Operated Calcium Entry in Tumor Invasion and Metastasis

Melanoma of skin

Pathology

Noorjahan Panjwani

The Role of Galectins in Corneal Hem- and Lymphangiogenesis

Melanoma of skin

Pathology

Elizabeth Grimm

Aberrant Silencing of a Large Micro-RNA Cluster on Chromosome 14q32 and its Relation to Aberrant c-MET/n-RAS Signaling in Cutaneous Malignant Melanoma-Implications for Novel Therapeutic Approaches and Biomarkers

Melanoma of skin

Pathology

Carl D Novina

(PQD1) Evolution of Vemurafenib Resistance in Circulating Melanoma Cells

Melanoma of skin

Pathology